Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma

Lipids

Volumn 50, Issue 10, 2015, Pages 977-985

  Qiu, Jian Feng ^a   Zhang, Ke Lin ^b   Zhang, Xiao Jing ^a   Hu, Yuan Jia ^a   Li, Peng ^a   Shang, Chang Zhen ^b   Wan, Jian Bo ^a  

^a University of Macau   (Macao)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gas chromatography mass spectrometry; Hepatocellular carcinoma; Multivariate statistical analysis; Plasma phospholipid fatty acid profile

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; LINOLENIC ACID; OLEIC ACID; PALMITIC ACID; STEARIC ACID; PHOSPHOLIPID; TUMOR MARKER;

ADULT; ANOREXIA; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID ANALYSIS; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; MASS FRAGMENTOGRAPHY; MIDDLE AGED; PATTERN RECOGNITION; TASTE AVERSION; AGED; BLOOD; CASE CONTROL STUDY; LIVER TUMOR; MULTIVARIATE ANALYSIS;

ADULT; AGED; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FATTY ACIDS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHOLIPIDS;

EID: 84942197525     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-015-4060-6     Document Type: Article

References (35)

1. Kassahun WT, Fangmann J, Harms J, Hauss J, Bartels M (2006) Liver resection and transplantation in the management of hepatocellular carcinoma: a review. Exp Clin Transpl 4:549-558
2. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
3. Njei B, Rotman Y, Ditah I, Lim JK (2015) Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 61:191-199
4. Bosetti C, Turati F, La Vecchia C (2014) Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 28:753-770
5. Zhang J, Zhang L, Ye X, Chen L, Zhang L, Gao Y, Kang JX, Cai C (2013) Characteristics of fatty acid distribution is associated with colorectal cancer prognosis. Prostaglandins Leukot Essent Fat Acids 88:355-360
6. Chaudry A, McClinton S, Moffat LE, Wahle KW (1991) Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease. Br J Cancer 64:1157-1160
7. Macleod RI, Cassidy D, Laker MF, Soames JV (1990) Fatty acid composition of clinically healthy and malignant oral epithelium. J Oral Pathol Med 19:149-151
8. Gao M, Sun K, Guo M, Gao H, Liu K, Yang C, Li S, Liu N (2015) Fish consumption and n-3 polyunsaturated fatty acids, and risk of hepatocellular carcinoma: systematic review and meta-analysis. Cancer Causes Control 26:367-376
9. Wan JB, Huang LL, Rong R, Tan R, Wang J, Kang JX (2010) Endogenously decreasing tissue n-6/n-3 fatty acid ratio reduces atherosclerotic lesions in apolipoprotein E-deficient mice by inhibiting systemic and vascular inflammation. Arterioscler Thromb Vasc Biol 30:2487-2494
10. Tan B, Liang Y, Yi L, Li H, Zhou Z, Ji X, Deng J (2010) Identification of free fatty acids profiling of type 2 diabetes mellitus and exploring possible biomarkers by GC-MS coupled with chemometrics. Metabolomics 6:219-228
11. Zhao C, Mao J, Ai J, Shenwu M, Shi T, Zhang D, Wang X, Wang Y, Deng Y (2013) Integrated lipidomics and transcriptomic analysis of peripheral blood reveals significantly enriched pathways in type 2 diabetes mellitus. BMC Med Genom 6:S12
12. Zhang XJ, Huang LL, Su HX, Chen YX, Huang J, He CW, Li P, Yang DZ, Wan JB (2014) Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach. J Pharm Biomed Anal 95:85-92
13. Wang DC, Sun CH, Liu LY, Sun XH, Jin XW, Song WL, Liu XQ, Wan XL (2012) Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging 33:1057-1066
14. Murphy RA, Bureyko TF, Mourtzakis M, Chu QS, Clandinin MT, Reiman T, Mazurak VC (2012) Aberrations in plasma phospholipid fatty acids in lung cancer patients. Lipids 47:363-369
15. Kobayakawa M, Yamawaki S, Hamazaki K, Akechi T, Inagaki M, Uchitomi Y (2005) Levels of omega-3 fatty acid in serum phospholipids and depression in patients with lung cancer. Br J Cancer 93:1329-1333
16. Tania M, Khan MA, Song Y (2010) Association of lipid metabolism with ovarian cancer. Curr Oncol 17:6-11
17. Cvetkovic Z, Vucic V, Cvetkovic B, Petrovic M, Ristic-Medic D, Tepsic J, Glibetic M (2010) Abnormal fatty acid distribution of the serum phospholipids of patients with non-Hodgkin lymphoma. Ann Hematol 89:775-782
18. Chajes V, Jenab M, Romieu I, Ferrari P, Dahm CC, Overvad K, Egeberg R, Tjonneland A, Clavel-Chapelon F, Boutron-Ruault MC, Engel P, Teucher B, Kaaks R, Floegel A, Boeing H, Trichopoulou A, Dilis V, Karapetyan T, Mattiello A, Tumino R, Grioni S, Palli D, Vineis P, Bueno-de-Mesquita HB, Numans ME, Peeters PHM, Lund E, Navarro C, Quiros JR, Sanchez-Cantalejo E, Gurrea AB, Dorronsoro M, Regner S, Sonestedt E, Wirfalt E, Khaw KT, Wareham N, Allen NE, Crowe FL, Rinaldi S, Slimani N, Carneiro F, Riboli E, Gonzalez CA (2011) Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Am J Clin Nutr 94:1304-1313
19. Chow CK (2009) Fatty acid composition of plasma phospholipids and risk of prostate cancer. Am J Clin Nutr 89:1946-1947
20. Al-Tamer YY, Mahmood AA (2004) Lipid components and fatty acid composition of Iraqi subjects who smoke and consume dairy products. Nutr Metab Cardiovasc Dis 14:94-96
21. Zhang XJ, Huang LL, Cai XJ, Li P, Wang YT, Wan JB (2013) Fatty acid variability in three medicinal herbs of Panax species. Chem Cent J 7:12
22. Zhang XJ, Qiu JF, Guo LP, Wang Y, Li P, Yang FQ, Su HX, Wan JB (2013) Discrimination of multi-origin Chinese herbal medicines using gas chromatography-mass spectrometry-based fatty acid profiling. Molecules 18:15329-15343
23. Wan JB, Bai X, Cai XJ, Rao Y, Wang YS, Wang YT (2013) Chemical differentiation of Da-Cheng-Qi-Tang, a Chinese medicine formula, prepared by traditional and modern decoction methods using UPLC/Q-TOFMS-based metabolomics approach. J Pharm Biomed Anal 83:34-42
24. Gallagher P, Tweedle DE (1983) Taste threshold and acceptability of commercial diets in cancer patients. JPEN J Parenter Enter Nutr 7:361-363
25. Mooppan MM, Subramanyam D, Gupta NM, Talwar BL (1977) Cholesterol and phospholipid concentrations in gall bladder and hepatic bile in patients with cholelithiasis. Indian J Med Res 65:232-235
26. McClinton S, Moffat LE, Horrobin DF, Manku MS (1991) Abnormalities of essential fatty acid distribution in the plasma phospholipids of patients with bladder cancer. Br J Cancer 63:314-316
27. Currie E, Schulze A, Zechner R, Walther TC, Farese RV Jr (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153-161
28. Hildebrandt LA, Spennetta T, Elson C, Shrago E (1995) Utilization and preferred metabolic pathway of ketone bodies for lipid synthesis by isolated rat hepatoma cells. Am J Physiol 269:C22-C27
29. Hanai T, Hashimoto T, Nishiwaki K, Ono M, Akamo Y, Tanaka M, Mizuno I, Yura J (1993) Comparison of prostanoids and their precursor fatty acids in human hepatocellular carcinoma and noncancerous reference tissues. J Surg Res 54:57-60
30. 13C nuclear magnetic resonance spectroscopy and gas liquid chromatography. Blood 85:1323-1330
31. Baro L, Hermoso JC, Nunez MC, Jimenez-Rios JA, Gil A (1998) Abnormalities in plasma and red blood cell fatty acid profiles of patients with colorectal cancer. Br J Cancer 77:1978-1983
32. Lv W, Yang T (2012) Identification of possible biomarkers for breast cancer from free fatty acid profiles determined by GC-MS and multivariate statistical analysis. Clin Biochem 45:127-133
33. Kurtova AV, Xiao J, Mo Q, Pazhanisamy S, Krasnow R, Lerner SP, Chen F, Roh TT, Lay E, Ho PL, Chan KS (2015) Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 517:209-213
34. Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295-315
35. Mayoral R, Fernandez-Martinez A, Bosca L, Martin-Sanz P (2005) Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. Carcinogenesis 26:753-761